Clinical Trials Browser

Unknown × Glioblastoma × sintilimab × Clear all

NCT05638451 2024-06-05

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

Phase 2 Unknown

Glioblastoma